Search Results

There are 3336 results for: content related to: Rediscovering alemtuzumab: current and emerging therapeutic roles

  1. Alemtuzumab for patients with chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Nicole Skoetz, Kathrin Bauer, Thomas Elter, Ina Monsef, Verena Roloff, Michael Hallek and Andreas Engert

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008078.pub2

  2. You have free access to this content
    Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 144, Issue 1, January 2009, Pages: 78–85, Claes Karlsson, Jeanette Lundin, Eva Kimby, Ben Kennedy, Paul Moreton, Peter Hillmen and Anders Österborg

    Article first published online : 4 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07451.x

  3. You have free access to this content
    An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

    British Journal of Haematology

    Volume 156, Issue 4, February 2012, Pages: 481–489, Agostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, Antonio Cuneo, Stefania Ciolli, Nicola Di Renzo, Pellegrino Musto, Francesca R. Mauro, Nicola Cascavilla, Lorenzo Falchi, Francesco Zallio, Vincenzo Callea, Francesco Maura, Sara Martinelli, Alfonso Piciocchi, Gianluigi Reda, Robin Foà and on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Party

    Article first published online : 9 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08965.x

  4. You have free access to this content
    Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 135, Issue 4, November 2006, Pages: 475–485, Mohammad Reza Rezvany, Mahmood Jeddi Tehrani, Claes Karlsson, Jeanette Lundin, Hodjattallah Rabbani, Anders Österborg and Håkan Mellstedt

    Article first published online : 22 SEP 2006, DOI: 10.1111/j.1365-2141.2006.06324.x

  5. You have free access to this content
    Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

    British Journal of Haematology

    Volume 144, Issue 1, January 2009, Pages: 95–98, Carmen D. Schweighofer, Matthias Ritgen, Barbara F. Eichhorst, Raymonde Busch, Wolfgang Abenhardt, Michael Kneba, Michael Hallek and Clemens-Martin Wendtner

    Article first published online : 4 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07394.x

  6. You have free access to this content
    Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

    British Journal of Haematology

    Volume 142, Issue 2, July 2008, Pages: 318–320, Eleni Tholouli, Effie Liakopoulou, Hayley M. Greenfield, Bronwen E. Shaw, Sudhir Tauro, Jennifer L. Byrne, Mike Dennis, John Burthem, Guy S. Lucas, Charles Craddock, Nigel H. Russell and John A. Liu Yin

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1365-2141.2008.07184.x

  7. You have free access to this content
    Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

    Cancer

    Volume 112, Issue 6, 15 March 2008, Pages: 1288–1295, John D. Hainsworth, Elizabeth R. Vazquez, David R. Spigel, Eric Raefsky, James D. Bearden, Ruben A. Saez and F. Anthony Greco

    Article first published online : 11 JAN 2008, DOI: 10.1002/cncr.23271

  8. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 101–109, Rebecca A. Marsh, Carl E. Allen, Kenneth L. McClain, Joanna L. Weinstein, Julie Kanter, Jodi Skiles, Nadine D. Lee, Shakila P. Khan, Julia Lawrence, Jun Q. Mo, Jack J. Bleesing, Alexandra H. Filipovich and Michael B. Jordan

    Article first published online : 22 APR 2012, DOI: 10.1002/pbc.24188

  9. You have free access to this content
    Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma

    British Journal of Haematology

    Volume 141, Issue 2, April 2008, Pages: 235–243, Wendy Ingram, Stephen Devereux, Emma P. Das-Gupta, Nigel H. Russell, Andrew P. Haynes, Jennifer L. Byrne, Bronwen E. Shaw, Andrew McMillan, Juan Gonzalez, Aloysius Ho, Ghulam J. Mufti and Antonio Pagliuca

    Article first published online : 3 MAR 2008, DOI: 10.1111/j.1365-2141.2008.07067.x

  10. Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

    European Journal of Haematology

    Volume 71, Issue 4, October 2003, Pages: 250–256, G. A. Kennedy, J. F. Seymour, M. Wolf, H. Januszewicz, J. Davison, C. McCormack, G. Ryan and H. M. Prince

    Article first published online : 1 SEP 2003, DOI: 10.1034/j.1600-0609.2003.00143.x

  11. You have free access to this content
    Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath-1H) in Cynomolgus Monkeys

    American Journal of Transplantation

    Volume 10, Issue 4, April 2010, Pages: 773–783, D. J. Van Der Windt, C. Smetanka, C. Macedo, J. He, R. Lakomy, R. Bottino, B. Ekser, G. J. Echeverri, D. Metes, J. N. M. Ijzermans, M. Trucco, D. K. C. Cooper and F. G. Lakkis

    Article first published online : 20 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03050.x

  12. You have free access to this content
    Ex Vivo-Expanded Cynomolgus Macaque Regulatory T Cells Are Resistant to Alemtuzumab-Mediated Cytotoxicity

    American Journal of Transplantation

    Volume 13, Issue 8, August 2013, Pages: 2169–2178, E. M. Dons, G. Raimondi, H. Zhang, A. F. Zahorchak, J. K. Bhama, L. Lu, M. Ezzelarab, J. N. M. Ijzermans, D. K. C. Cooper and A. W. Thomson

    Article first published online : 1 MAY 2013, DOI: 10.1111/ajt.12248

  13. You have free access to this content
    Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab

    British Journal of Haematology

    Volume 132, Issue 1, January 2006, Pages: 3–12, Karin A. Thursky, Leon J. Worth, John F. Seymour, H. Miles Prince and Monica A. Slavin

    Article first published online : 10 OCT 2005, DOI: 10.1111/j.1365-2141.2005.05789.x

  14. You have free access to this content
    Phase II study of alemtuzumab in chronic lymphoproliferative disorders

    Cancer

    Volume 98, Issue 4, 15 August 2003, Pages: 773–778, Alessandra Ferrajoli, Susan M. O'Brien, Jorge E. Cortes, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Razelle Kurzrock, Susan Lerner, Dimitrios P. Kontoyiannis and Michael J. Keating

    Article first published online : 26 JUN 2003, DOI: 10.1002/cncr.11551

  15. You have free access to this content
    Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia

    Cancer

    Volume 107, Issue 10, 15 November 2006, Pages: 2408–2416, Michael Fiegl, Andreas Falkner, Georg Hopfinger, Stefan Brugger, August Zabernigg, Franz Bauer, Ferdinand Haslbauer, Dita Demirtas, Peter Grossschmidt, Georg Tatzreiter, Günther Gastl, Richard Greil and The Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia

    Article first published online : 19 OCT 2006, DOI: 10.1002/cncr.22263

  16. You have free access to this content
    Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia

    Cancer

    Volume 119, Issue 12, 15 June 2013, Pages: 2258–2267, Georg Hopfinger, Raymonde Busch, Natali Pflug, Nicole Weit, Anne Westermann, Anna-Maria Fink, Paula Cramer, Nina Reinart, Dirk Winkler, Günter Fingerle-Rowson, Stephan Stilgenbauer, Hartmut Döhner, Gabriele Kandler, Barbara Eichhorst, Michael Hallek and Marco Herling

    Article first published online : 19 MAR 2013, DOI: 10.1002/cncr.27972

  17. You have free access to this content
    The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

    Pediatric Transplantation

    Volume 18, Issue 1, February 2014, Pages: 94–102, Pooja Khandelwal, Julia Lawrence, Alexandra H. Filipovich, Stella M. Davies, Jacob J. Bleesing, Michael B. Jordan, Parinda Mehta, Sonata Jodele, Michael S. Grimley, Ashish Kumar, Kasiani Myers and Rebecca A. Marsh

    Article first published online : 30 OCT 2013, DOI: 10.1111/petr.12183

  18. Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin

    Transplant Infectious Disease

    Volume 11, Issue 5, October 2009, Pages: 413–423, S.H. Park, S.-M. Choi, D.-G. Lee, J.-H. Choi, J.-H. Yoo, S.-H. Kim, H.-J. Kim, S.-G. Cho, K.-S. Eom, J.-W. Lee, W.-S. Min, W.-S. Shin and C.-C. Kim

    Article first published online : 24 AUG 2009, DOI: 10.1111/j.1399-3062.2009.00414.x

  19. You have free access to this content
    Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

    British Journal of Haematology

    Volume 145, Issue 2, April 2009, Pages: 173–179, Liuyan Jiang, Constance M. Yuan, Julia Hubacheck, John E. Janik, Wyndham Wilson, John C. Morris, Gregory A. Jasper and Maryalice Stetler-Stevenson

    Article first published online : 19 FEB 2009, DOI: 10.1111/j.1365-2141.2009.07606.x

  20. You have free access to this content
    Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 125, Issue 3, May 2004, Pages: 294–317, D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes and D. Milligan

    Article first published online : 1 APR 2004, DOI: 10.1111/j.1365-2141.2004.04898.x